These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26363026)
1. Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists. Hutzler JM; Ring BJ; Anderson SR Drug Metab Dispos; 2015 Dec; 43(12):1917-28. PubMed ID: 26363026 [TBL] [Abstract][Full Text] [Related]
2. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Chan TS; Yu H; Moore A; Khetani SR; Tweedie D Drug Metab Dispos; 2013 Dec; 41(12):2024-32. PubMed ID: 23959596 [TBL] [Abstract][Full Text] [Related]
3. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the Biotransformation of Low-Turnover Drugs in the H Burton RD; Hieronymus T; Chamem T; Heim D; Anderson S; Zhu X; Hutzler JM Drug Metab Dispos; 2018 Nov; 46(11):1617-1625. PubMed ID: 30135244 [TBL] [Abstract][Full Text] [Related]
5. Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG. Bonn B; Svanberg P; Janefeldt A; Hultman Ia; Grime K Drug Metab Dispos; 2016 Apr; 44(4):527-33. PubMed ID: 26851239 [TBL] [Abstract][Full Text] [Related]
6. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Jones HM; Houston JB Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339 [TBL] [Abstract][Full Text] [Related]
7. Evaluation and Optimization of a Microcavity Plate-Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates. Kukla DA; Belair DG; Stresser DM Drug Metab Dispos; 2024 Jul; 52(8):797-812. PubMed ID: 38777596 [TBL] [Abstract][Full Text] [Related]
8. Generation of major human excretory and circulating drug metabolites using a hepatocyte relay method. Ballard TE; Orozco CC; Obach RS Drug Metab Dispos; 2014 May; 42(5):899-902. PubMed ID: 24608634 [TBL] [Abstract][Full Text] [Related]
9. Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450. Smith S; Lyman M; Ma B; Tweedie D; Menzel K Drug Metab Dispos; 2021 Nov; 49(11):995-1002. PubMed ID: 34407991 [TBL] [Abstract][Full Text] [Related]
10. Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac. Chan TS; Yu H; Moore A; Khetani SR; Tweedie D Drug Metab Dispos; 2019 Jan; 47(1):58-66. PubMed ID: 30552098 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds. Preiss LC; Georgi K; Lauschke VM; Petersson C Drug Metab Dispos; 2024 May; 52(6):539-547. PubMed ID: 38604730 [TBL] [Abstract][Full Text] [Related]
12. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model. Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143 [TBL] [Abstract][Full Text] [Related]
13. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions. Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146 [TBL] [Abstract][Full Text] [Related]
14. Micropatterned coculture of hepatocytes on electrospun fibers as a potential in vitro model for predictive drug metabolism. Liu Y; Wei J; Lu J; Lei D; Yan S; Li X Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():475-84. PubMed ID: 27040241 [TBL] [Abstract][Full Text] [Related]
15. In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo Metabolism. Kamel A; Bowlin S; Hosea N; Arkilo D; Laurenza A Drug Metab Dispos; 2021 Feb; 49(2):121-132. PubMed ID: 33273044 [TBL] [Abstract][Full Text] [Related]
16. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds. Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099 [TBL] [Abstract][Full Text] [Related]
17. Advances in Engineered Human Liver Platforms for Drug Metabolism Studies. Underhill GH; Khetani SR Drug Metab Dispos; 2018 Nov; 46(11):1626-1637. PubMed ID: 30135245 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053 [TBL] [Abstract][Full Text] [Related]
19. Application of chimeric mice with humanized liver for study of human-specific drug metabolism. Bateman TJ; Reddy VG; Kakuni M; Morikawa Y; Kumar S Drug Metab Dispos; 2014 Jun; 42(6):1055-65. PubMed ID: 24700822 [TBL] [Abstract][Full Text] [Related]
20. A novel relay method for determining low-clearance values. Di L; Trapa P; Obach RS; Atkinson K; Bi YA; Wolford AC; Tan B; McDonald TS; Lai Y; Tremaine LM Drug Metab Dispos; 2012 Sep; 40(9):1860-5. PubMed ID: 22645091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]